PUBLIC HEALTH INFORMATION

Pfizer’s COVID-19 Vaccine 94 Percent Effective in Adults Aged Over 65: Trial

Google LogoMark Us Preferred on Google
Pfizer’s COVID-19 Vaccine 94 Percent Effective in Adults Aged Over 65: Trial
A patient receiving Pfizer's COVID-19 vaccine at the University of Maryland School of Medicine in Baltimore, Md., on May 4, 2020. Courtesy of University of Maryland School of Medicine via AP
Zachary Stieber
Zachary Stieber
Senior Reporter
|Updated:

One of the leading COVID-19 vaccine candidates was 94 percent effective in adults older than 65, according to new clinical trial results.

New York-based Pfizer and Germany-based BioNTech said Wednesday their phase 3 study of the candidate concluded after meeting all primary endpoints.

Google LogoMark Us Preferred on Google
Zachary Stieber
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
twitter
truth
Related Topics